… the effects of PAM and aspirin. Aspirin (30 μmol L −1 ) alone caused complete inhibition
of the production of TXA 2 in response to AA (Fig. 3A), collagen (Fig. 3B) and epinephrine (Fig. …

… of aspirin in these populations found a 20% reduction in CV events [Citation1]. Clopidogrel
was the first P2Y12 inhibitor to be evaluated as an alternative to aspirin … that P2Y12 inhibitors …

… Dual antiplatelet therapy (DAPT) with aspirin and a P2Y 12 platelet adenosine diphosphate
(ADP) … Effects of pretreatment with clopidogrel and aspirin followed by long‐term therapy in …

… a P2Y12 inhibitor or DAPT (1-12 months) compared to a VKA plus DAPT (1-12 months).
However, the use of prasugrel and ticagrelor … with using newer oral P2Y12 inhibitors as part of …

… P2Y12 inhibitor monotherapy compared with conventional dual antiplatelet therapy (DAPT)
and aspirin … categorized as P2Y12 inhibitor monotherapy (P2Y12 inhibitor monotherapy after …

… with an irreversible mode of action, received approval in 1997 following the CAPRIE trial, a
randomized comparison of clopidogrel alone vs. aspirin alone in patients with atherosclerotic …

… To summarise our hypothesis, when aspirin is used alone as an antithrombotic agent in
high-risk patients, its potentially deleterious cardiovascular effects are more than balanced by its …

… DAPT followed by monotherapy with aspirin alone with long-term DAPT … aspirin monotherapy
after 3 months of DAPT especially in patients presenting with ACS. As P2Y12 inhibitors …

… comparison between ticagrelor and aspirin from 12 … ticagrelor alone or ticagrelor and aspirin
according to the GLOBAL LEADERS protocol13. Continuation of aspirin on top of ticagrelor …

… ) with aspirin plus a P2Y12 inhibitor or dual pathway inhibition (DPI) with aspirin plus a …
) trial showing that, compared to aspirin alone, DPI was more effective in preventing ischemic …